Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
168.4 USD | -0.86% | +1.41% | +10.47% |
04-30 | TD Cowen Adjusts Price Target on Universal Health Services to $183 From $181, Keeps Hold Rating | MT |
04-26 | Leerink Partners Adjusts Price Target on Universal Health Services to $195 From $192 | MT |
Summary
- The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
- The company presents an interesting fundamental situation from a short-term investment perspective.
Strengths
- Over the past year, analysts have regularly revised upwards their sales forecast for the company.
- Growth remains a strong point in this company. In their sales forecast, analysts sound optimistic with regard to sales prospects.
- For the last twelve months, analysts have been gradually revising upwards their EPS forecast for the upcoming fiscal year.
- For the last 4 months, the company has been enjoying highly positive EPS revisions, which were frequently and significantly raised.
- The average price target of analysts who are interested in the stock has been strongly revised upwards over the last four months.
- Consensus analysts have strongly revised their opinion of the company over the past 12 months.
- There is high visibility into the group's activities for the coming years. Outlooks on future revenues from analysts covering the equity remain similar. Such hardly dispersed estimates support highly predictable sales for the current and upcoming fiscal years.
- The divergence of price targets given by the various analysts who make up the consensus is relatively low, suggesting a consensus method of evaluating the company and its prospects.
- The group usually releases upbeat results with huge surprise rates.
Weaknesses
- The firm pays small or no dividend to shareholders. For that reason, it is not a yield company.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Healthcare Facilities & Services
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+10.47% | 11.44B | B- | ||
+14.12% | 81.68B | C+ | ||
-29.28% | 69.23B | B- | ||
+9.72% | 29.08B | C+ | ||
-11.80% | 16.88B | B | ||
-0.43% | 16.85B | A- | ||
-1.06% | 15.15B | A- | ||
+3.42% | 12.62B | A- | ||
+30.60% | 12.47B | B- | ||
-30.70% | 11.89B | - | - |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- UHS Stock
- Ratings Universal Health Services, Inc.